1. Home
  2. WAL vs HALO Comparison

WAL vs HALO Comparison

Compare WAL & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Alliance Bancorporation (DE)

WAL

Western Alliance Bancorporation (DE)

HOLD

Current Price

$83.14

Market Cap

8.8B

Sector

Finance

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$81.76

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAL
HALO
Founded
1994
1998
Country
United States
United States
Employees
3769
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
8.1B
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
WAL
HALO
Price
$83.14
$81.76
Analyst Decision
Buy
Buy
Analyst Count
14
11
Target Price
$91.69
$78.64
AVG Volume (30 Days)
881.6K
1.7M
Earning Date
04-21-2026
05-05-2026
Dividend Yield
2.11%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.22
Revenue
N/A
$151,862,000.00
Revenue This Year
$20.49
$28.24
Revenue Next Year
$8.08
$12.56
P/E Ratio
$10.88
$66.26
Revenue Growth
N/A
N/A
52 Week Low
$65.82
$57.68
52 Week High
$97.23
$82.26

Technical Indicators

Market Signals
Indicator
WAL
HALO
Relative Strength Index (RSI) 54.83 66.67
Support Level $82.86 $67.12
Resistance Level $84.75 $82.24
Average True Range (ATR) 2.20 2.47
MACD 0.11 0.08
Stochastic Oscillator 76.49 86.92

Price Performance

Historical Comparison
WAL
HALO

About WAL Western Alliance Bancorporation (DE)

Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: